AtriCure Inc

ATRC

Equity

ISIN null / Valor 2134051

NASDAQ (2026-03-31)

USD 28.53+0.96%

AtriCure Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

AtriCure Inc. is a prominent medical device company specializing in the development and provision of advanced technologies aimed at the treatment of Atrial Fibrillation (Afib) and related cardiac conditions. The company has established itself as a trusted partner for electrophysiologists and cardiothoracic surgeons globally, offering a range of products designed to address complex cardiac cases. Among its notable innovations is the Isolator® Synergy™ Ablation System, distinguished as the first device of its kind to receive FDA approval for the treatment of persistent Afib. Additionally, AtriCure's AtriClip Left Atrial Appendage Exclusion System stands out as the most extensively utilized device worldwide for left atrial appendage management. The company also offers the Hybrid AF™ Therapy, a minimally invasive approach catering to patients with long-standing persistent Afib, and the cryoICE cryoSPHERE® probe, which is approved for the temporary ablation of peripheral nerves to alleviate pain during cardiac and thoracic surgeries. AtriCure is committed to advancing the field of cardiac care through continuous investment in innovation, clinical science, and educational initiatives aimed at enhancing patient outcomes globally.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-11.6%1Y

-31.2%3Y

-56.5%5Y

Performance

48.5%1Y

47.4%3Y

47.0%5Y

Volatility